| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |